Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
artemisia douglasiana pollen
- Development stage
- Approved
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Epicutaneous, Intradermal
01
Overview
Artemisia douglasiana pollen is the allergenic extract derived from the California Mugwort (Artemisia douglasiana), a plant native to western North America. The primary medical use of this extract is in allergy testing and diagnosis of sensitivity to Artemisia species pollens. It may be used as part of skin prick tests or intradermal tests by allergy specialists to identify allergic reactions in patients suspected of having hay fever or other respiratory allergies related to Artemisia pollens[1][2][4]. The mechanism of action involves eliciting an immune response in sensitized individuals; it does not have a pharmacological effect but serves as a diagnostic tool for IgE-mediated hypersensitivity.
- Brand names
- california mugwort pollencalifornia mugwort pollen extractdouglas' mugwort pollen
- Other names
- artemisia heterophylla pollencalifornia mugwort pollencalifornia mugwort pollen extractdouglas' mugwort pollen
02
Targets
A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)
Beyond the preview
Go deeper on artemisia douglasiana pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on artemisia douglasiana pollen.